EBI3 and COVID-19: Amongst these pathways 7 of 16 were involved in anti-viral immunity (‘viral protein interaction with cytokine and cytokine receptor’, ‘Toll-like receptor signaling pathway’, ‘coronavirus disease—COVID-19′, ‘influenza A’, ‘measles’, ‘epstein-Barr virus infection’, and ‘human cytomegalovirus infection’) (Figure 2B).